Researchers at Mass General Brigham have created a new hydrogel to improve drug delivery for treating PTOA. The hydrogel ...

Switzerland-based EsoCap has built a novel drug delivery system that aims to provide long-lasting local therapy in the upper gastrointestinal tract and is currently being tested in a phase 2 trial.

"We showed that we can have very controlled, sustained delivery ... the drug release rate, extending its duration while maintaining injectability. This demonstrates the tunability of our system ...

A new hydrogel offers sustained drug release for post-traumatic osteoarthritis, improving treatment effectiveness during joint movement.

Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal ...